Acupuncture and moxibustion therapy for cognitive impairment: the microbiome-gut-brain axis and its role

Jiatian Shi1, Xinyue Zhang1, Jianhua Chen2

  • 1Department of Acupuncture and Moxibustion, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Frontiers in Neuroscience
|January 26, 2024
PubMed

Insights

Acupuncture and moxibustion may improve cognitive impairment by modulating the microbiome-gut-brain axis. This therapy influences gut microbes, inflammation, and intestinal barrier function for neurodegenerative disease treatment.

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Integrative Medicine

Background:

  • Cognitive impairment presents a global health challenge with limited effective treatments.
  • The microbiome-gut-brain (MGB) axis is increasingly recognized for its role in cognitive decline.
  • Acupuncture and moxibustion show therapeutic potential in degenerative diseases.

Purpose of the Study:

  • To review the mechanisms of acupuncture and moxibustion in improving cognitive impairment via the MGB axis.
  • To explore how this therapy impacts gut microbial homeostasis, inflammation, and intestinal barrier function.
  • To identify key acupoints and their mechanistic relevance for MGB axis intervention.

Main Methods:

  • Literature review of studies on acupuncture, moxibustion, cognitive impairment, and the MGB axis.
  • Analysis of proposed biological pathways linking MGB axis modulation to cognitive function.
  • Discussion of specific acupoints and their potential therapeutic effects.

Main Results:

  • Acupuncture and moxibustion may restore gut microbial balance.
  • Therapy can mitigate neuroendocrine-immune-mediated intestinal inflammation.
  • Enhanced intestinal barrier function is a potential outcome of treatment.

Conclusions:

  • Acupuncture and moxibustion offer a promising therapeutic avenue for cognitive impairment by targeting the MGB axis.
  • Further research into specific acupoints and mechanisms can optimize MGB-targeted interventions.
  • This approach holds potential for managing neurodegenerative diseases.